MindWalk Holdings Corp.
HYFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001715925
No open-market purchases or sales by MindWalk Holdings Corp. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $6.90M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 27
- 13F valueReported value at the end of Q2 2026
- $6.90M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HYFT, Q2 2026
No superinvestor reported holding HYFT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by MindWalk Holdings Corp. insiders from Form 4, newest first.
No open-market purchases or sales by MindWalk Holdings Corp. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in MindWalk Holdings Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ingalls & Snyder LLC | 3,035,479 | $4.80M | 0.13% | +128,439+4.4% | Added |
| Susquehanna International Group, LLP | 520,769 | $822.8K | 0.00% | −13,247−2.5% | Reduced |
| Renaissance Technologies LLC | 213,380 | $337.1K | 0.00% | −19,100−8.2% | Reduced |
| BlackRock, Inc. | 154,411 | $244.0K | 0.00% | +154,411 | New |
| Marshall Wace, LLP | 135,967 | $214.8K | 0.00% | +110,721+438.6% | Added |
| Bank of Montreal | 77,947 | $123.2K | 0.00% | +8,000+11.4% | Added |
| Allianz Asset Management GmbH | 35,000 | $55.3K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 34,525 | $55.0K | 0.00% | +34,525 | New |
| Gradient Capital Advisors, LLC | 26,551 | $42.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 25,490 | $40.3K | 0.00% | +9,356+58.0% | Added |